SOPHiA Clinical Exome Solution v3
From data to insights to confident care
With new and improved probe design, rare and inherited disorder analyses benefit from increased detection capabilities within the entire mitochondrial genome, as well as non-coding variants known to be disorder-causing, for a deeper investigation of Mendelian disorders.
SOPHiA Clinical Exome Solution v3 offers a streamlined end-to-end workflow (from sample to variant report), that streamlines and facilitates the assessment of challenging Mendelian disorders, freeing up time and resources. The solution bundles a capture-based target enrichment kit with the analytical capabilities and interpretation-support functionalities of SOPHiA DDM™ platform, offering deep coverage of the target regions and accurate analysis of multiple type of variants (SNVs, Indels and CNVs) in one unique experiment. As a result, we help you efficiently find the pathogenic needle in the big data haystack, and improving turnaround time.
Dedicated features to ease variant interpretation
The SOPHiA DDM™ platform features intuitive variant filters and prioritization options to streamline the interpretation process and help you greatly reduce turnaround time.
- Dual Variant Pre-classification to improve assessment of variants pathogenicity based on both ACMG scores and our machine learning-based predictions
- Virtual Panel to restrict the interpretation to sub-panels of genes using the HPO or OMIM browser
- Cascading Filters to apply custom filtering options for quicker screening of relevant variants and save strategies for future analyses
- Familial Variant Analysis to quickly identify causative variants by selecting different inheritance modes with a single mouse click to shorten the candidate variant list accordingly
Through SOPHiA DDM™, you can also have access to Alamut Visual Plus, a full-genome browser that integrates numerous curated genomic and literature databases, guidelines, missense and slicing predictors, thus enabling a deeper variant exploration.
Full coverage of the mitochondrial genome coupled with sensitive variant calling
The probe design is highly optimized to guarantee high on-target reads percentage and coverage uniformity even in GC-rich regions, including the first exon. With SOPHiA Clinical Exome Solution v3, you get full mitochondrial genome variant detection, including non-coding variants, now in 280 genomic locations. Additionally, with improved analytical performance, you can reach more than 90% analytical sensitivity for CNV detection*.
|Diseases covered||Rare and inherited disorders|
|No. of genes covered||4,728
Entire mitochondrial genome
~ 200 non-coding variants with known pathogenicity in deep introns/enhancer/promoter genes
|Target region size||16 Mb|
|DNA input amount||200 ng|
|Library prep time||1.5 days|
|Analysis time from FASTQ||Overnight|
Request a demo
Please fill out the form below to request a demo
SOPHiA Whole Exome Solution
SOPHiA DDM™ for KAPA HyperExome
(*Data on file. Results may vary. Sensitivity of CNV detection in two consecutive regions (exons) with 40 million fragments (80 million reads) based on internal data.)